Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Illumina Laboratory Services, |
RCV000015426 | SCV000914462 | pathogenic | Mannose-binding lectin deficiency | 2018-12-11 | criteria provided, single submitter | clinical testing | The MLB2 c.154C>T (p.Arg52Cys) missense variant, commonly referred to as the "D" allele, has been described in at least one study in individuals with recurrent infections and low serum MBP levels in which it was found in a compound heterozygous state with another missense variant in one individual with a very low serum MBP level and in a homozygous state in another individual with no detectable serum MBP level (Summerfield et al. 1995). The p.Arg52Cys variant has also been investigated in healthy unrelated individuals with low or undetectable MBP levels (Madsen et al. 1994; Babovic-Vuksanovic et al. 1999) and found at a frequency of 0.05 in both the African and Caucasian populations in both a compound heterozygous state and a heterozygous state. Functional studies by Liu et al. (2012) showed that the p.Arg52Cys variant did not affect gene transcription or protein secretion, but did result in a lower level of oligomerization, a loss of ability to bind mannan, a reduced ability to bind to MASP1 and MASP2 and failed to activate the complement system. However, it should be noted that MBL deficiency is very common. The p.Arg52Cys variant is reported at a frequency of is 0.11111 in the Finnish population of the 1000 Genomes Project. While the allele frequency for this variant appears to be high, multiple studies referenced in this paragraph have shown a significant over-representation of this variant in individuals with low levels of mannose-binding lectin as compared to controls. Many individuals who carry MBL2 variants classified as pathogenic do not develop clinical complications. Based on the evidence, the p.Arg52Cys variant is classified as pathogenic for mannose-binding lectin deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
| Ce |
RCV002274881 | SCV002563004 | uncertain significance | not provided | 2021-07-01 | criteria provided, single submitter | clinical testing | |
| Invitae | RCV002274881 | SCV003453490 | benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
| Center for Genomic Medicine, |
RCV000015426 | SCV004806905 | benign | Mannose-binding lectin deficiency | 2024-03-26 | criteria provided, single submitter | clinical testing | |
| OMIM | RCV000015426 | SCV000035690 | pathogenic | Mannose-binding lectin deficiency | 2006-08-01 | no assertion criteria provided | literature only | |
| Center for Computational Genomics and Data Science, |
RCV000991134 | SCV001142521 | risk factor | Cystic fibrosis | 2019-04-01 | no assertion criteria provided | research |